Oral Immunotherapy With Inactivated Nontypeable Haemophilus influenzae Reduces Severity of Acute Exacerbations in Severe COPD
Authors:
- Martin PhillipsMPMartin Phillips
- Grant WatererGWGrant Waterer
- Margaret DunkleyMDMargaret Dunkley
- Phillip ComansPCPhillip Comans
- Robert ClancyRCRobert Clancy
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- COPD exacerbations: defining their cause and preventionThe Lancet, 2007
- Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2007
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2002
- Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Acute on chronic bronchitis: A model of mucosal immunologyImmunology & Cell Biology, 1995
- Reduction in the Incidence of Acute Bronchitis by an Oral Haemophilus influenzae Vaccine in Patients with Chronic Bronchitis in the Highlands of Papua New GuineaAmerican Review of Respiratory Disease, 1991
- Bacterial colonisation of the respiratory tract in chronic bronchitisAustralian and New Zealand Journal of Medicine, 1990
- ORAL IMMUNISATION WITH KILLED HAEMOPHILUS INFLUENZAE FOR PROTECTION AGAINST ACUTE BRONCHITIS IN CHRONIC OBSTRUCTIVE LUNG DISEASEThe Lancet, 1985